retatrutide type 2 diabetes phase 2 trial results 2024 ESC 2024: improves lipid and cardiovascular risk profile in II retatrutide type 2 diabetes phase

Arrange transportation : It is important to arrange for someone to drive you home after the procedure, as the injection may cause temporary numbness or weakness in the hand

Objective This study aimed to develop and implement GLP-1RA prescription review rules through a multidisciplinary information pharmacist team, evaluate their impact on prescription rationality, and identify ADE risk signals using real-world data, thereby promoting rational clinical medication use and ensuring patient safety

Dermatol 53 (4), 555568

Most patients self-administer their injections at home once weekly after instruction from our team